CMV infection in liver transplantation under cyclosporine or FK 506 immunosuppression
- PMID: 1721351
- PMCID: PMC2962613
CMV infection in liver transplantation under cyclosporine or FK 506 immunosuppression
Figures



Similar articles
-
FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease.Transplant Proc. 1993 Apr;25(2):1992-3. Transplant Proc. 1993. PMID: 7682360 No abstract available.
-
Cytomegalovirus infection of the upper gastrointestinal tract following liver transplantation--incidence, location, and severity in cyclosporine- and FK506-treated patients.Transplantation. 1992 Apr;53(4):786-91. doi: 10.1097/00007890-199204000-00016. Transplantation. 1992. PMID: 1373535 Free PMC article. Clinical Trial.
-
Incidence of cytomegalovirus infection and disease in orthotopic liver transplant patients immunosuppressed with cyclosporin versus tacrolimus.Transplant Proc. 2002 Aug;34(5):1567-8. doi: 10.1016/s0041-1345(02)03025-7. Transplant Proc. 2002. PMID: 12176488 No abstract available.
-
Clinical use of FK 506 in liver transplantation.Transplant Proc. 1996 Apr;28(2):974-6. Transplant Proc. 1996. PMID: 8623484 Review.
-
Neoral is superior to FK 506 in liver transplantation.Transplant Proc. 1998 Aug;30(5):1812-5. doi: 10.1016/s0041-1345(98)00442-4. Transplant Proc. 1998. PMID: 9723293 Review. No abstract available.
References
-
- Paya CV, Hermans PE, Washington JA, et al. Mayo Clin Proc. 1989;64:555. - PubMed
-
- Dunn DL, Simmons RL. Infect Surg. 1989;8:164.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical